Molecular Biology of the Hepatitis B Virus for Clinicians

Journal of Clinical and Experimental Hepatology

Volumn 2, Issue 4, 2012, Pages 353-365

  Datta, Sibnarayan ^a   Chatterjee, Soumya ^a   Veer, Vijay ^a   Chakravarty, Runu ^b  

^a Defence R D Organization   (India)

^b INDIAN COUNCIL OF MEDICAL RESEARCH   (India)

Author keywords

Genotype; HBsAg; Hepadnavirus; PgRNA; RcDNA

Indexed keywords

GENOMIC DNA; GENOMIC RNA; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B(E) ANTIGEN; NUCLEIC ACID; RIBONUCLEASE;

BIOACCUMULATION; DNA REPAIR; DNA STRAND; GENE AMPLIFICATION; GENE EXPRESSION; GENE MUTATION; GENETIC VARIABILITY; GENOTYPE; HEPATITIS B VIRUS; HISTORY OF MEDICINE; INFECTIOUS HEPATITIS; LIFE CYCLE; MOLECULAR BIOLOGY; MOLECULAR DYNAMICS; MOLECULAR PATHOLOGY; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; REVIEW; SEQUENCE ANALYSIS; SIGNAL TRANSDUCTION; VIRUS ATTACHMENT; VIRUS CELL INTERACTION; VIRUS ENTRY; VIRUS GENE; VIRUS IDENTIFICATION; VIRUS MORPHOLOGY; VIRUS PARTICLE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

EID: 84871049979     PISSN: 09736883     EISSN: 22133453     Source Type: Journal    
DOI: 10.1016/j.jceh.2012.10.003     Document Type: Review

References (116)

1. EASL Clinical Practice Guidelines: management of chronic hepatitis B. J Hepatol 2012, 57:167-185. European Association for the Study of the Liver.
2. Beasley R.P., Hwang L.Y., Lin C.C., Chien C.S. Hepatocellular carcinoma and hepatitis B virus. A prospective study of 22,707 men in Taiwan. Lancet 1981, 2:1129-1133.
3. Shepard C.W., Simard E.P., Finelli L., Fiore A.E., Bell B.P. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol Rev 2006, 28:112-125.
4. Seeger C., Mason W.S. Hepatitis B virus biology. Microbiol Mol Biol Rev 2000, 64:51-68.
5. Lurman A. Eine icterus epidemic. Berl Klin Woschenschr 1885, 22:20-23. [in German].
6. Sherlock S., Dooley J. Viral hepatitis. Disease of the Liver and Biliary System 1997, 265-302. Blackwell Science Ltd, Milan. 10th ed. S. Sherlock, J. Dooley (Eds.).
7. Zuckerman A.J. The chronicle of viral hepatitis. Bull Hyg Trop Dis 1997, 54:113.
8. Blumberg B.S., Alter H.J., Visnich S.A. A new antigen in leukemia sera. JAMA 1965, 191:541-546.
9. Krugman S., Giles J.P., Hammond J. Infectious hepatitis: evidence for two distinctive clinical, epidemiological, and immunological types of infection. JAMA 1967, 200:365-373.
10. Dane D.S., Cameron C.H., Briggs M. Virus-like particles in serum of patients with Australia-antigen-associated hepatitis. Lancet 1970, 1:695-698.
11. Robinson W.S., Clayton D.A., Greenman R.L. DNA of a human hepatitis B virus candidate. J Virol 1974, 14:384-391.
12. Kaplan P.M., Greenman R.L., Gerin J.L., Purcell R.H., Robinson W.S. DNA polymerase associated with human hepatitis B antigen. J Virol 1973, 12:995-1005.
13. Ganem D., Schneider R.J. Hepadnaviridae: the viruses and their replication. Fields Virology 2001, 2923-2969. Lippincott Williams & Wilkins, Philadelphia. 4th ed. D.M. Knipe, P.M. Howley (Eds.).
14. Summers J., O'Connell A., Millman I. Genome of hepatitis B virus: restriction enzyme cleavage and structure of DNA extracted from Dane particles. Proc Natl Acad Sci U S A 1975, 72:4597-4601.
15. Landers T.A., Greenberg H.B., Robinson W.S. Structure of hepatitis B Dane particle DNA and nature of the endogenous DNA polymerase reaction. J Virol 1977, 23:368-376.
16. Delius H., Gough N.M., Cameron C.H., Murray K. Structure of the B virus genome. J Virol 1983, 47:337-343.
17. Haines K.M., Loeb D.D. The sequence of the RNA primer and the DNA template influence the initiation of plus-strand DNA synthesis in hepatitis B virus. J Mol Biol 2007, 370:471-480.
18. Kidd-Ljunggren K., Miyakawa Y., Kidd A.H. Genetic variability in hepatitis B viruses. J Gen Virol 2002, 83:1267-1280.
19. Kay A., Zoulim F. Hepatitis B virus genetic variability and evolution. Virus Res 2007, 127:164-176.
20. Bartenschlager R., Schaller H. The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J 1988, 7:4185-4192.
21. Kwee L., Lucito R., Aufiero B., Schneider R.J. Alternate translation initiation on hepatitis B virus X mRNA produces multiple polypeptides that differentially transactivate class II and III promoters. J Virol 1992, 66:4382-4389.
22. Summers J., Mason W.S. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 1982, 29:403-415.
23. Ganem D., Pollack J.R., Tavis J. Hepatitis B virus reverse transcriptase and its many roles in hepadnaviral genomic replication. Infect Agents Dis 1994, 3:85-93.
24. Seeger C., Mason W.S. Replication of the hepatitis virus genome. DNA Replication in Eukaryotic Cells 1996, 815-831. ColdSpringHarbor Laboratory Press, New York. M.L. DePamphilis (Ed.).
25. Pontisso P., Morsica G., Ruvoletto M.G., et al. Hepatitis B virus binds to peripheral blood mononuclear cells via the pre S1 protein. J Hepatol 1991, 12:203-206.
26. Petit M.A., Capel F., Dubanchet S., Habit H. PreSl-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Virology 1992, 187:211-222.
27. Dash S., Rao K.V.S., Panda S.K. Receptor for pre-SI (21-47) component of hepatitis B virus on the liver cell: role in virus cell interaction. J Med Virol 1992, 37:116-121.
28. Mehdi H., Kaplan M.J., Anlar F.Y., et al. Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 1994, 68:2415-2424.
29. Pontisso P., Petit M.A., Bankowski M.J., Peeples M.E. Human liver plasma membranes contain receptors for the hepatitis B virus preS1 region and, via polymerized human serum albumin, for the preS2 region. J Virol 1989, 63:1981-1988.
30. Kuroki K., Eng F., Ishikawa T., Turck C., Harada F., Ganem D. gp180, a host cell glycoprotein that binds duck hepatitis B virus particles is encoded by a member of the carboxypeptidase gene family. J Biol Chem 1995, 270:15022-15028.
31. Neurath A.R., Strick N., Sproul P. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J Exp Med 1992, 175:461-469.
32. Jin Y.M., Churchill N.D., Michalak T.I. Protease-activated lymphoid cell and hepatocyte recognition site in the preS1 domain of the large woodchuck hepatitis virus envelope protein. J Gen Virol 1996, 77:1837-1846.
33. Kock J., Schlicht H.J. Analysis of the earliest steps of hepadnavirus replication: genome repair after infectious entry into hepatocytes does not depend on viral polymerase activity. J Virol 1993, 67:4867-4874.
34. Cattaneo R., Will H., Schaller H. Hepatitis B virus transcription in the infected liver. EMBO J 1984, 3:2191-2196.
35. Enders G.H., Ganem D., Varmus H. Mapping the major transcripts of ground squirrel hepatitis virus: the presumptive template for reverse transcriptase is terminally redundant. Cell 1985, 42(1):297-308.
36. Wu H.L., Chen P.J., Tu S.J., Lin M.H., Lai M.Y., Chen D.S. Characterization and genetic analysis of alternatively spliced transcripts of hepatitis B virus in infected human liver tissues and transfected HepG2 Cells. J Virol 1991, 65:1680-1686.
37. Soussan P., Tuveri R., Nalpas B., et al. The expression of hepatitis B spliced protein (HBSP) encoded by a spliced hepatitis B virus RNA is associated with viral replication and liver fibrosis. J Hepatol 2003, 38:343-348.
38. Milich D.R., Chen M.K., Hughes J.L., Jones J.E. The secreted hepatitis B precore antigen can modulate the immune response to the nucleocapsid: a mechanism for persistence. J Immunol 1998, 160:2013-2021.
39. Chang C., Zhou S., Ganem D., Standring D.N. Phenotypic mixing between different hepadnavirus nucleocapsid proteins reveals C protein dimerization to be cis preferential. J Virol 1994, 68:5225-5231.
40. Crowther R.A., Kiselev N.A., Böttcher B., et al. Three-dimensional structure of hepatitis B virus core particles determined by electron cryomicroscopy. Cell 1994, 77:943-950.
41. Zlotnick A., Cheng N., Conway J.F., et al. Dimorphism of hepatitis B virus capsids is strongly influenced by the C-terminus of the capsid protein. Biochem 1996, 35:7412-7421.
42. Wynne S.A., Crowther R.A., Leslie A.G. The crystal structure of the human hepatitis B virus capsid. Mol Cell 1999, 3:771-780.
43. Heermann K.H., Kruse F., Seifer M., Gerlich W.H. Immunogenicity of the gene S and pre-S domains in hepatitis B virions and HBsAg filaments. Intervirology 1987, 28:14-25.
44. Chen D.S. From hepatitis to hepatoma: lessons from type B viral hepatitis. Science 1993, 262:369-370.
45. Bouchard M.J., Schneider R.J. The enigmatic X gene of hepatitis B virus. J Virol 2004, 78:12725-12734.
46. Tang H., Oishi N., Kaneko S., Murakami S. Molecular functions and biological roles of hepatitis B virus X protein. Cancer Sci 2006, 97:977-983.
47. Murakami S. Hepatitis B virus X protein: structure, function and biology. Intervirology 1999, 42:81-99.
48. Pang R., Tse E., Poon R.T.P. Molecular pathways in hepatocellular carcinoma. Cancer Lett 2006, 240:157-169.
49. Elmore L.W., Hancock A.R., Chang S.F., et al. Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci U S A 1997, 94:14707-14712.
50. Wang H.C., Huang W., Lai M.D., Su I.J. Hepatitis B virus pre-S mutants, endoplasmic reticulum stress and hepatocarcinogenesis. Cancer Sci 2006, 97:683-688.
51. Caselmann W.H. Transactivation of cellular gene expression by hepatitis B viral proteins: a possible molecular mechanism of hepatocarcinogenesis. J Hepatol 1995, 22(suppl):34-37.
52. Chang L.J., Pryciak P., Ganem D., Varmus H.E. Biosynthesis of the reverse transcriptase of hepatitis B viruses involves de novo translational initiation not ribosomal frameshifting. Nature 1989, 337:364-368.
53. Bartenschlager R., Schaller H. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J 1992, 11:3413-3420.
54. Junker-Niepmann M., Bartenschlager R., Schaller H. A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J 1990, 9:3389-3396.
55. Bartenschlager R., Junker-Niepmann M., Schaller H. The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J Virol 1990, 64:5324-5332.
56. Hirsch R.C., Lavine J.E., Chang L.J., Varmus H.E., Ganem D. Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature 1990, 344:552-555.
57. Pollack J.R., Ganem D. An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J Virol 1993, 67:3254-3263.
58. Rieger A., Nassal M. Specific hepatitis B virus minus-strand DNA synthesis requires only the 5' encapsidation signal and the 3'-proximal direct repeat DR1. J Virol 1996, 70:585-589.
59. Wang G.H., Seeger C. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 1992, 71:663-670.
60. Weber M., Bronsema V., Bartos H., Bosserhoff A., Bartenschlager R., Schaller H. Hepadnavirus P protein utilizes a tyrosine residue in the TP domain to prime reverse transcription. J Virol 1994, 68:2994-2999.
61. Zoulim F., Seeger C. Reverse transcription in hepatitis B viruses is primed by a tyrosine residue of the polymerase. J Virol 1994, 68:6-13.
62. Nassal M., Rieger A. A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis. J Virol 1996, 70:2764-2773.
63. Hu J., Boyer M. Hepatitis B virus reverse transcriptase and ε RNA sequences required for specific interaction in vitro. J Virol 2006, 80:2141-2150.
64. Gerlich W.H., Robinson W.S. Hepatitis B virus contains protein covalently attached to the 5' terminus of its complete DNA strand. Cell 1980, 21:801-809.
65. Lien J.M., Aldrich C.E., Mason W.S. Evidence that a capped oligo-ribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J Virol 1986, 57:229-236.
66. Loeb D.L., Hirsch R.C., Ganem D. Sequence-independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B viruses: implications for other reverse transcribing elements. EMBO J 1991, 10:3533-3540.
67. Will H., Reiser W., Weimer T., et al. Replication strategy of human hepatitis B virus. J Virol 1987, 61:904-911.
68. Havert M.B., Loeb D.D. cis-acting sequences in addition to donor and acceptor sites are required for template switching during synthesis of plus-strand DNA for duck hepatitis B virus. J Virol 1997, 71:5336-5344.
69. Lutwick L.I., Robinson W.S. DNA synthesized in the hepatitis B Dane particle DNA polymerase reaction. J Virol 1977, 21:96-104.
70. Staprans S., Loeb D.D., Ganem D. Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J Virol 1991, 65:1255-1262.
71. Yang W., Summers J. Illegitimate replication of linear hepadnavirus DNA through nonhomologous recombination. J Virol 1995, 69:4029-4036.
72. Yang W., Summers J. Integration of hepadnavirus DNA in infected liver: evidence for a linear precursor. J Virol 1999, 73:9710-9717.
73. Tuttleman J.S., Pourcel C., Summers J. Formation of the pool of covalently closed circular viral DNA in hepadnavirus-infected cells. Cell 1986, 47:451-460.
74. Summers J., Smith P.M., Horwich A.L. Hepadnavirus envelope proteins regulate covalently closed circular DNA amplification. J Virol 1990, 64:2819-2824.
75. Jilbert A.R., Wu T.T., England J.M., et al. Rapid resolution of duck hepatitis B virus infections occurs after massive hepatocellular involvement. J Virol 1992, 66:1377-1388.
76. Kajino K., Jilbert A.R., Saputelli J., Aldrich C.E., Cullen J., Mason W.S. A study of woodchuck hepatitis virus infections revealed very rapid recovery after a prolonged viremia and infection of virtually every hepatocyte. J Virol 1994, 68:5792-5803.
77. Huovila A.P., Eder A.M., Fuller S.D. Hepatitis B surface antigen assembles in a post-ER, pre-Golgi compartment. J Cell Biol 1992, 118:1305-1320.
78. Bonhoeffer S., Sniegowski P. Virus evolution: the importance of being erroneous. Nature 2002, 420:367-369.
79. Okamoto H., Imai M., Kametani M., Nakamura T., Mayumi M. Genomic heterogeneity of hepatitis B virus in a 54-year-old woman who contracted the infection through materno-fetal transmission. Jpn J Exp Med 1987, 57:231-236.
80. Orito E., Mizokami M., Ina Y., et al. Host-independent evolution and a genetic classification of the hepadnavirus family based on nucleotide sequences. Proc Natl Acad Sci U S A 1989, 86:7059-7062.
81. Mizokami M., Orito E., Ohba K., Ikeo K., Lau J.Y., Gojobori T. Constrained evolution with respect to gene overlap of hepatitis B virus. J Mol Evol 1997, 44:S83-S90.
82. Sterneck M., Gunther S., Gerlach J., et al. Hepatitis B virus sequence changes evolving in liver transplant recipients with fulminant hepatitis. J Hepatol 1997, 26:754-764.
83. Blackberg J., Kidd-Ljunggren K. Occult hepatitis B virus after acute self-limited infection persisting for 30 years without sequence variation. J Hepatol 2000, 33:992-997.
84. Norder H., Courouce A.M., Coursaget P., et al. Genetic diversity of hepatitis B virus strains derived worldwide: genotypes, subgenotypes, and HBsAg subtypes. Intervirology 2004, 47:289-309.
85. Okamoto H., Tsuda F., Sakugawa H., et al. Typing hepatitis B virus by homology in nucleotide sequence: comparison of surface antigen subtypes. J Gen Virol 1988, 69:2575-2583.
86. Kramvis A., Kew M., Francois G. Hepatitis B virus genotypes. Vaccine 2005, 23:2407-2421.
87. Schaefer S. Hepatitis B virus: significance of genotypes. J Viral Hepat 2005, 12:111-124.
88. Thedja M.D., Muljono D.H., Nurainy N., Sukowati C.H., Verhoef J., Marzuki S. Ethnogeographical structure of hepatitis B virus genotype distribution in Indonesia and discovery of a new subgenotype, B9. Arch Virol 2011, 156:855-868.
89. Mulyanto, Depamede S.N., Wahyono A., et al. Analysis of the full-length genomes of novel hepatitis B virus subgenotypes C11 and C12 in Papua, Indonesia. J Med Virol 2011, 83:54-64.
90. Meldal B.H., Moula N.M., Barnes I.H., Boukef K., Allain J.P. A novel hepatitis B virus subgenotype, D7, in Tunisian blood donors. J Gen Virol 2009, 90:1622-1628.
91. Devesa M., Loureiro C.L., Rivas Y., et al. Subgenotype diversity of hepatitis B virus American genotype F in Amerindians from Venezuela and the general population of Colombia. J Med Virol 2008, 80:20-26.
92. Tran T.T., Trinh T.N., Abe K. New complex recombinant genotype of hepatitis B virus identified in Vietnam. J Virol 2008, 82:5657-5663.
93. Tatematsu K., Tanaka Y., Kurbanov F., et al. A genetic variant of hepatitis B virus divergent from known human and ape genotypes isolated from a Japanese patient and provisionally assigned to new genotype J. J Virol 2009, 83:10538-10547.
94. Simmonds P., Midgley S. Recombination in the genesis and evolution of hepatitis B virus genotypes. J Virol 2005, 79:15467-15476.
95. Tabor E., Purcell R.H., London W.T., Gerety R.J. Use of and interpretation of results using inocula of hepatitis B virus with known infectivity titers. J Infect Dis 1983, 147:531-534.
96. Chu C.J., Lok A.S.F. Clinical significance of hepatitis B virus genotypes. Hepatology 2002, 35:1274-1276.
97. Tanaka Y., Mizokami M. Genetic diversity of hepatitis B virus as an important factor associated with differences in clinical outcomes. J Infect Dis 2007, 195:1-4.
98. Guettouche T., Hnatyszyn H.J. Chronic hepatitis B and viral genotype: the clinical significance of determining HBV genotypes. Antivir Ther 2005, 10:593-604.
99. Lin C.L., Kao J.H. The clinical implications of hepatitis B virus genotype: recent advances. J Gastroenterol Hepatol 2011, 26(suppl 1):123-130.
100. Datta S. An overview of molecular epidemiology of hepatitis B virus (HBV) in India. Virol J 2008, 5:156.
101. Wang H.P., Rogler C.E. Topoisomerase-I mediated integration of hepadnavirus DNA in vitro. J Virol 1991, 65:2381-2392.
102. Su T.S., Lai C.J., Huang J.L., et al. Hepatitis B virus transcript produced by RNA splicing. J Virol 1989, 63:4011-4018.
103. Gunther S. Genetic variation in HBV infection: genotypes and mutants. J Clin Virol 2006, 36:S3-S11.
104. Kramvis A., Kew M. The core promoter of hepatitis B virus. J Viral Hepat 1999, 6:415-427.
105. Kuang S.Y., Jackson P.E., Wang J.B., et al. Specific mutations of hepatitis B virus in plasma predict liver cancer development. Proc Natl Acad Sci U S A 2004, 101:3575-3580.
106. Su I.J., Wang H.C., Wu H.C., Huang W.Y. Ground glass hepatocytes contain pre-S mutants and represent preneoplastic lesions in chronic hepatitis B virus infection. J Gastroenterol Hepatol 2008, 23:1169-1174.
107. Pawlotsky J.M. The concept of hepatitis B virus mutant escape. J Clin Virol 2005, 34(suppl 1):S125-S129.
108. Torresi J. The virological and clinical significance of mutations in the overlapping envelope and polymerase genes of hepatitis B virus. J Clin Virol 2002, 25:97-106.
109. Carman W.F., Zanetti A.R., Karayiannis P., et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990, 336:325-329.
110. Cooreman M.P., Leroux-Roels G., Paulij W.P. Vaccine- and hepatitis B immune globulin-induced escape mutations of hepatitis B virus surface antigen. J Biomed Sci 2001, 8:237-247.
111. Hoofnagle J.H., Doo E., Liang T.J., Fleischer R., Lok A.S. Management of hepatitis B: summary of a clinical research workshop. Hepatology 2007, 45:1056-1075.
112. Stuyver L.J., Locarnini S.A., Lok A., et al. Nomenclature for antiviral-resistant human hepatitis B virus mutations in the polymerase region. Hepatology 2001, 33:751-757.
113. Angus P., Vaughan R., Xiong S., et al. Resistance to adefovir dipivoxil therapy associated with development of a novel mutation in the HBV polymerase. Gastroenterology 2003, 125:292-297.
114. Locarnini S., Yuen L. Molecular genesis of drug resistant and vaccine escape HBV mutants. Anitvir Ther 2010, 15:451-461.
115. Kim K.H., Kim N.D., Seong B.L. Discovery and development of anti-HBV agents and their resistance. Molecules 2010, 15:5878-5908.
116. Datta S., Banerjee A., Chandra P.K., et al. Analysis of hepatitis B virus X gene phylogeny, genetic variability and its impact on pathogenesis: implications in Eastern Indian HBV carriers. Virology 2008, 382:190-198.